Patents by Inventor Silvio Bicciato

Silvio Bicciato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230332159
    Abstract: The present disclosure provides materials and methods for the delivery of therapeutic nucleic cells (and imaging agents) to tissues.
    Type: Application
    Filed: November 11, 2022
    Publication date: October 19, 2023
    Inventors: Paolo Serafini, Dimitri Van Simaeys, Adriana De La Fuente, Alessia Zoso, Silvio Bicciato, Jimmy Caroli, Cristian Taccioli, Andrea Grilli, Midhat Abdulreda
  • Patent number: 11584935
    Abstract: The present disclosure provides materials and methods for the delivery of therapeutic nucleic cells (and imaging agents) to tissues.
    Type: Grant
    Filed: May 8, 2019
    Date of Patent: February 21, 2023
    Assignees: UNIVERSITY OF MIAMI, UNIVERSITY OF MODENA AND REGGIO EMILLA—UNIMORE
    Inventors: Paolo Serafini, Dimitri Van Simaeys, Adriana De La Fuente, Alessia Zoso, Silvio Bicciato, Jimmy Caroli, Cristian Taccioli, Andrea Grilli, Midhat Abdulreda
  • Publication number: 20220175935
    Abstract: Described herein and RNA aptamers that specifically bind to tumor-infiltrating myeloid cells and uses thereof.
    Type: Application
    Filed: March 3, 2020
    Publication date: June 9, 2022
    Inventors: Paolo Serafini, Silvio Bicciato, Jimmy Caroli, Adriana De La Fuente, Dimitri Van Simaeys, Serena Zilio, Vincenzo Bronte
  • Publication number: 20210139907
    Abstract: The present disclosure provides materials and methods for the delivery of therapeutic nucleic cells (and imaging agents) to tissues.
    Type: Application
    Filed: May 8, 2019
    Publication date: May 13, 2021
    Inventors: Paolo Serafini, Dimitri Van Simaeys, Adriana De La Fuente, Alessia Zoso, Silvio Bicciato, Jimmy Caroli, Cristian Taccioli, Andrea Grilli, Midhat Abdulreda
  • Publication number: 20150322533
    Abstract: The present invention relates to the expression of two genes, CyclinG2 and Sharp1, which correlates with prognosis in individuals having breast cancer. Specifically, this invention provides a method to stratify samples from breast cancer patients in a high or low recurrence risk in the years following primary tumor removal. This classification can be achieved through the analysis of protein or mRNA expression levels for the two identified genes. The invention also illustrates how CyclinG2 and Sharp1 have been identified in mammary cancer cell lines and validated in a large cohort of human patients as powerful metastasis predictors.
    Type: Application
    Filed: July 28, 2015
    Publication date: November 12, 2015
    Inventors: Stefano PICCOLO, Michelangelo CORDENONSI, Maddalena ADORNO, Silvio BICCIATO
  • Publication number: 20120035069
    Abstract: The present invention relates to the expression of two genes, CyclinG2 and Sharp1, which correlates with prognosis in individuals having breast cancer. Specifically, this invention provides a method to stratify samples from breast cancer patients in a high or low recurrence risk in the years following primary tumor removal. This classification can be achieved through the analysis of protein or mRNA expression levels for the two identified genes. The invention also illustrates how CyclinG2 and Sharp1 have been identified in mammary cancer cell lines and validated in a large cohort of human patients as powerful metastasis predictors.
    Type: Application
    Filed: January 21, 2009
    Publication date: February 9, 2012
    Inventors: Stefano Piccolo, Michelangelo Cordenonsi, Maddalena Adorno, Silvio Bicciato